Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (24658)	8/18/1998 12:07:00 AM
From: bob zagorin	Respond to of 32384

regarding Henry's post. imo, they fall into three general categories. 1) has to do with science, research etc. sometimes they're too technical but, in general, they are very informative and pretty objective, imo, for someone so committed to the stock. i have a lot of faith in their accuracy. 2) have to do with stock price movements, "big boys" etc. they're of no particular value to me; i can take 'em or leave 'em. 3) ongoing debate with "naysayers". i don't expect henry to take the crap they dish out without defending himself or the stock, but i wish he would avoid taking tony's bait. i've watched the the decline and believe it's technical and related to temporary factors. so i've put my money where my mouth is. wish tony would the same. come on tony, put some money on the table. i dare you.

To: Henry Niman who wrote (24658)	8/18/1998 3:35:00 AM
From: PAR	Read Replies (1) \| Respond to of 32384

Mr. Niman, you keep repeating in your posts: >> and LGND is projected to be profitable in 1999. << but based on a chart several posts back, you could have made the same statement for 1998? What evidence is there that LGND will not disappoint again? __________________ NEW YORK, Aug 17 (Reuters) - The following companies reported the greatest deviations above or below analysts' mean estimates. Earnings surprise data provided by Zacks Investment Research. Company Ticker Actual Cons Surp. ... LIGAND PHARMA-B (NASDAQ:LGND) -0.45 $0.35 -29 ...